Unilever Buys Grüns for $1.2B: What It Signals for Supplements
On June 1, 2026, Unilever completed its acquisition of Grüns, an American greens supplement brand, for $1.2 billion. A brand founded in 2023, hitting a $1.2B valuation in 3 years. And it's Unilever's third major wellness acquisition in less than 18 months.
This isn't just a transaction. It's a clear signal about the state of the supplement market — and where Big Consumer money is going next.
Key Facts
- Price: $1.2B for a brand founded in 2023
- Grüns: 1M+ customers, 10M gummies/day, in Target, Walmart, Costco, Sam's Club
- Unilever wellness portfolio: Olly + SmartyPants + Onnit + Grüns
- Parallel pattern: Danone buys Huel (~$1.15B) | Lonza sells Metagenics | Herbalife acquires Bioniq
Who Is Grüns and Why It Was Worth $1.2B
Grüns launched in 2023 with a simple concept: 60 active ingredients in one daily gummy. 30+ organic fruits and vegetables, 21 vitamins and minerals, 6g of prebiotic fiber. Maximum convenience positioning — no powder to measure, no capsule to swallow.
By acquisition date, the numbers: over 1 million customers, 95,000+ five-star reviews, 10 million gummies shipped daily, and distribution in Target, Walmart, Costco, Sam's Club, and Sprouts — transforming a DTC brand into a mass-market player.
What industrial buyers acquire in these deals is rarely the product formula. It's the loyal customer base, retention data, and distribution growth capacity. Grüns had all three.
Unilever's Strategy: Building a Wellness Empire
With Grüns, Unilever's wellness portfolio now includes Olly (vitamin gummies), SmartyPants (complete nutrition), Onnit (cognitive performance), and Grüns (daily nutrition). Four brands, four different positions in the VMS (vitamins, minerals, supplements) market — near-complete coverage of the mainstream wellness spectrum.
The industrial logic is straightforward: the global protein and sports supplement market is projected to reach $43.98 billion by 2031 (7.7% CAGR, Mordor Intelligence, June 2026). Margins in premium supplements are 5-8x higher than standard grocery. In that context, $1.2B to buy 1 million loyal consumers isn't a premium — it's a market entry.
A Consolidation Wave Reshaping the Industry
The Grüns acquisition isn't isolated. In 2026, the sector is seeing accelerated consolidation:
- Danone acquires Huel for ~$1.15B. Complete nutrition, DTC platform, functional profile. Same logic.
- Lonza sells Capsule & Health Ingredients to Lone Star Funds — even infrastructure players are optimizing portfolios
- Metagenics acquires Symprove (probiotics) — microbiome consolidation
- Function raises $298M Series B at $2.5B valuation — personalized health diagnostics as the next wellness frontier
The picture that's forming: consumer goods leaders are exiting low-margin categories and entering premium wellness. DTC brands with proven retention metrics are becoming the most sought-after assets in the sector.
What It Means for Independent Brands
For brands not yet on Big Consumer's radar, two readings apply.
The pessimistic one: with Unilever, Danone, Herbalife and others entering DTC wellness with massive marketing budgets and distribution capabilities, competing head-on with an independent brand is increasingly difficult.
The optimistic one: the $1.2B valuation for a 3-year-old brand confirms that large groups need acquisitions to innovate — they can't build these brands internally. That means independent brands that build a loyal customer base and solid retention metrics become attractive acquisition targets.
The winning challenger strategy: own a precision niche that large groups can't serve with mass-market brands (e.g., sports-specific nutrition, protocol-based products for specific conditions, niche community brands).
Sources: Unilever — Grüns acquisition press release (June 2026) | Axios Pro — Unilever values Grüns at $1.2B (April 2026) | GlobeNewswire — Protein supplements market CAGR 7.7% by 2031 (June 2026)